Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Inventory (2016 - 2025)

Cytosorbents' Change in Inventory history spans 15 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly results put Change in Inventory at $1.3 million for Q4 2025, up 472.62% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (up 608.0% YoY), and the annual figure for FY2025 was $2.5 million, up 608.0%.
  • Change in Inventory for Q4 2025 was $1.3 million at Cytosorbents, up from $322000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.3 million in Q4 2025 to a low of -$1.7 million in Q1 2023.
  • The 5-year median for Change in Inventory is $309631.5 (2023), against an average of $163096.1.
  • The sharpest move saw Change in Inventory surged 535820.97% in 2021, then crashed 311.17% in 2023.
  • Year by year, Change in Inventory stood at $251496.0 in 2021, then plummeted by 293.21% to -$485918.0 in 2022, then soared by 159.38% to $288549.0 in 2023, then crashed by 220.26% to -$347000.0 in 2024, then skyrocketed by 472.62% to $1.3 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $1.3 million, $322000.0, and $726198.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.